Beneficios económicos del implante coclear para la hipoacusia sensorineural profunda

Peñaranda, Augusto; Mendieta, Juan Carlos; Perdomo, Jorge Andrés; Aparicio, Maria Leonor; Marín, Lina Marcela; García, Juan Manuel Méjica; Barón, Clemencia

doi:10.1590/s1020-49892012000400009

Cited by 18 publications

(10 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[34][35][36][37] According to WHO, the target price for an "affordable" hearing aid should be no more than 3% of the per capita of the user's country. 34 When this definition was proposed, 3% of the per capita gross national product of Bangladesh, India, Kenya, Malawi and Nigeria was 26, 46, 26, 10 and 43 United States dollars (US$), respectively.…”

Section: Reducing the Burdenmentioning

confidence: 99%

The global burden of disabling hearing impairment: a call to action

Olusanya

Neumann

Saunders

2014

Bull. World Health Organ.

431

380

View full text Add to dashboard Cite

Section: Reducing the Burdenmentioning

confidence: 99%

The global burden of disabling hearing impairment: a call to action

Olusanya

Neumann

Saunders

2014

Bull. World Health Organ.

431

380

View full text Add to dashboard Cite

“…A bottom-up methodology for calculation costs of outpatient treatment in children with pneumococcal AOM and adults with CAP was made, taken the costs from taken the costs from the Drug Price Information System (SISMED, acronym in Spanish) (39). Cochlear implant total costs for the treatment of profound sensorineural hearing loss in children were taken from an economic analysis published in Colombia in 2012 (40), and the costs were adjusted for the year 2019 based on the accumulated consumer-price index for the period 2012-2019 (Table 3).…”

Section: Estimating Resources and Costsmentioning

confidence: 99%

Pneumococcal Diseases Caused by Serotype Replacement in Colombia: A Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccines in Infants and Its Herd Protection in Older Adults

Ordóñez¹,

Ordóñez²

2020

Preprint

View full text Add to dashboard Cite

Background. The recent and available evidence on the distribution of pneumococcal serotypes, which affects the effectiveness of pneumococcal conjugate vaccines (PCV), suggest that additional health economic studies will be important for better understanding of potential economic benefits of pneumococcal vaccination. Methods A cohort simulation model was used for new births in Colombia between 2019-2022 and adults over 65 years, from social perspective (direct and indirect costs). The time horizon was a life expectancy and discount rate for costs and benefits of 5%. The outcomes were presented in terms of avoided pneumococcal diseases ─ Invasive Pneumococcal Disease (IPD), Community Acquired Pneumonia (CAP), Acute Otitis Media (AOM), and sequelae─, years of life gained (AVG) and herd effect in older adults.Results. Based on data from National Data of the serotype distribution between 2017-2019, PCV10 covers 5% of serotypes while PCV13 63%. The additional cases that PCV13 would prevent are in children: 1,205 cases of IPD, 60,274 of CAP, 26,619 of AOM, 3,980 deaths, 28 cases of neuromotor disability and 1,251 cochlear implants. In older adults, PCV13 would prevent 818 additional cases of IPD and 29,983 of CAP, generating 149,186 additional LYGs to those of PCV10 with a saving to the health system and patients of US $ 169,261 thousand. The model shows robustness in the sensibility analysis.Conclusion. PCV13 is a cost-saving strategy versus PCV10 to prevent pneumococcal diseases.

show abstract

“…DOI: http://doi.org/10.17352/2455-1759.000084 detection diffi cult [8,9]. On the other hand, it is reported that with reference to the etiology of sensorineural hearing loss, this is unknown in approximately 30% of cases [10] for this reason is necessary to perform Universal Neonatal Auditory Screening (UNAS) [11,12].…”

Section: The National Center Of Technological Excellence In Health Ofmentioning

confidence: 99%

Risk factors associated with the diagnosis of Sensorineural Hearing Loss in children

Gutiérrez-Farfán¹,

Reyes-Legorreta²,

Alatorre-Miguel³

et al. 2018

Arch Otolaryngol Rhinold

View full text Add to dashboard Cite

The hearing loss is the most frequent sensory alteration of the human being, with numerous medical, social, emotional and cultural implications. It is a multicausal pathology and is related to many risk factors. Identify the risk factors for the appearance of hearing loss in the child. Method: A sample of 81 children under 3 years of age with severe to profound sensorineural hearing loss was taken, in which the variables studied were the risk factors for hearing loss defi ned by the Joint Committee on Infant Hearing. Results: Values of the risk factors were found, with the following percentages: hypoxia (55.41%), gestational age less than 30 weeks (27%), weight less than 1500 grams (17.57%), ototoxic drugs (17.57%), jaundice with exsanguineous-transfusion (10.81%), meningitis (9.46%), jaundice treated with phototherapy (9.46%) and TORCH (6.76%). It was found that patients with hearing loss can present one to four risk factors, while in relation to sex again; the hypoxia risk factor has the highest percentage (male 31.59% and female 37.5%). Conclusions: It is clear that the patients analyzed have one or several risk factors related to hearing loss. In our case, hypoxia was the factor that most occurred. Therefore, without the realization of a hearing screening for early detection of deafness, the average age of diagnosis is around three years, when parents or educators begin to detect the fi rst manifestations.

show abstract

Beneficios económicos del implante coclear para la hipoacusia sensorineural profunda

Abstract: The cochlear implant produces economic benefits for the patient. It also produces health utilities since positive cost-utility (gain in decibels) and cost-effectiveness (gain in language discrimination) ratios were found.

Cited by 18 publications

References 14 publications

The global burden of disabling hearing impairment: a call to action

The global burden of disabling hearing impairment: a call to action

Pneumococcal Diseases Caused by Serotype Replacement in Colombia: A Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccines in Infants and Its Herd Protection in Older Adults

Risk factors associated with the diagnosis of Sensorineural Hearing Loss in children

Contact Info

Product

Resources

About